IL4I1 and nonpapillary renal cell carcinoma: Taken overall, IL4I1 might activate CCL2-CCR2 via JAK1/STAT3 signaling pathway further to promote M2-like macrophages polarization which enhances ccRCC immune escape and malignant behaviors.